Extracorporeal treatment of acute liver failure

Hepatology Research

Volumn 38, Issue SUPPL. 1, 2008, Pages

  Brophy, Colleen M ^a   Nyberg, Scott L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acute liver failure; Albumin dialysis; Bioartificial liver; Blood detoxification; Liver support device

Indexed keywords

AMANTADINE; PARACETAMOL;

ALBUMIN DIALYSIS; BIOARTIFICIAL LIVER; BRAIN DEATH; BRAIN EDEMA; CLINICAL TRIAL; CONFERENCE PAPER; DETOXIFICATION; DIALYSATE; DISEASE MODEL; HUMAN; KIDNEY FAILURE; LIVER FAILURE; LIVER SUPPORT; LIVER TRANSPLANTATION; LUNG EDEMA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 58049090165     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00424.x     Document Type: Conference Paper

References (31)

1. Khashab M, Tector A, Hwo P. Epidemiology of acute liver failure. Curr Gastroenterol Rep 2007; 9: 66-73.
2. Ostapowicz G, Fontana R, Schiodt F, Larson A, Davern T, Han S et al. Results of a prospective study of acute liver failure at 17 tertirary care centers in the United States. Ann Intern Med 2002; 137: 947-54.
3. Rozga J, Umehara Y, Trofimenko A, Sadahiro T, Demetriou A et al. A novel plasma filtration therapy for hepatic failure: Preclinical studies. Ther Apher Dial 2006; 10:(2): 138-44.
4. Murphy N. An update in acute liver failure: When to transplant and the role of liver support devices. Clin Med 2006; 6:(1): 40-6.
5. Krisper P, Haditsch B, Stauber R. In vivo quantification of liver dialysis: Comparison of albumin dialysis and fractionated plasma separation. J Hepatol 2005; 43: 451-7.
6. Rifai K, Manns M. Clinical experience with Prometheus (review article). Ther Apher Dial 2006; 10: 132-37.
7. Stange J, Hassanein T, Mehta R, Mitzner S, Bartlett R et al. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: A summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 2002; 26: 103-10.
8. Patzer J, Bane S. Bound solute dialysis. ASAIO 2003; 49: 271-81.
9. Patzer J. Principles of bound solute dialysis. Ther Apher Dial 2006; 10: 118-24.
10. Patzer J, Safta S, Miller R. Slow continuous ultrafiltration with bound solute dialysis. ASAIO 2006; 52: 47-58.
11. Falkenhagen D, Strobl W, Vogt G, Schrefl A, Linsberger I, Gerner F et al. Fractionated plasma separation and adsorption system: A novel system for blood purification to remove albumin bound substances. Artif Organs 1999; 23: 81-6.
12. Stange J, Mitzner S, Risler T, Erley C, Lauchart W, Goehl H et al. Molecular adsorbent recycling system (MARS): Clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999; 23: 319-30.
13. Stange J, Hassanein R, Mehta R, Lynch P, Larsen F, Tofteng F et al. Short-term survival of patients with severe intractable hepatic encephalopathy: The role of albumin dialysis. Hepatology 2005; 42: 286A.
14. Schmidt L, Wang L, Hansen B, Larsen F. Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trial. Liver Transpl 2003; 9: 290-7.
15. Skwarek A, Grodzicki M, Nyckowski P, Kotulski M, Zieniewicz K, Michalowicz W et al. The use prometheus FPSA system in the treatment of acute liver failure: Preliminary results. Transpl Proceed 2006; 38: 209-11.
16. Evenepoel P, Laleman W, Wilmer A, Claes K, Kuypers D, Bammens B et al. Prometheus versus molecular adsorbents recirculating system: Comparison of efficiency in two different liver detoxification devices. Artif Organs 2006; 30: 276-84.
17. Kjaergard L, Liu J, Als-Nielsen B, Gluud C etal. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure. JAMA 2003; 289: 217-22.
18. Matsumura K, Guevara G, Huston H, Hamilton W, Rikimaru M, Yamasaki G et al. Hybrid bioartificial liver in hepatic failure: Preliminary clinical report. Surgery 1987; 101: 99-103.
19. Sauer I, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G et al. Clinical extracorporeal hybrid liver support -phase 1 study with primary porcine liver cells. Xenotransplantation 2003; 10: 460-9.
20. Margulis M, Erukhimov E, Andreiman L, Viksna L. Temporary organ substitution by hemoperfusion through suspension of active donor hepatocytes in a total complex of intensive therapy in patients with acute hepatic insufficiency. Resuscitation 1989; 18: 85-94.
21. Patzer J, Kramer D, Mazariegos G, Lopez-Solis R, Giraldo M, Grogan T et al. Clinical Safety evaluation of Excorp Medical Inc. bioartificial liver support system (BLSS). ASAIO J 2000; 46: 241A.
22. Millis J, Losanoff J. Technology insight: Liver support systems. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 398-405.
23. Demetriou A, Brown R, Busuttil R, Fair J, McGuire B, Rosenthal P et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239: 660-70.
24. Mazariegos G, Kramer D, Lopez R, Shakil A, Rosenbloom A, DeVera M et al. Safety observations in phase I clinical evaluation of the excorp medical bioartificial liver support system after the first four patients. ASAIO J 2001; 47: 471-5.
25. Sosef M, Abrahamse L, Van de Kerkhove M, Hartman R, Chamuleau R, Van Gulik T et al. Assessment of the AMC-Bioartificial liver in the anhepatic pig. Transplantation 2002; 73: 204-9.
26. Millis L, Kramer D, O'Grady J, Heffron T, Caldwell S, Hart M et al. Results of phase I trial of the extracorporeal liver assist device for patients with fulminant hepatic failure. Am J Transplant 2001; 1(Suppl 1): 391.
27. Watanabe F, Mullon CJ-P, Hewitt W, Arkadopoulos N, Kahaku E, Eguchi S etal. Clinical experience with a bioartifical liver (BAL) in the treatment of severe liver failure: A phase I clinical trial. Ann Surg 1997; 225: 484-94.
28. Nyberg S, Hardin J, Amiot B, Argikar U, Remmel RP, Rinaldo P. et al. Rapid, large-scale formation of porcine hepatocyte spheroids in a novel spheroid reservoir bioartificial liver. Liver Transpl 2005; 11: 901-10.
29. Nyberg S, Cerra F, Gruetter R. Brain lactate by magnetic resonance spectroscopy during fulminant hepatic failure in the dog. Liver Transpl Surg 1997; 4: 158-65.
30. Nyberg S. Galactosamine-induced fulminant hepatic failure (letter to editor). Hepatology 1997; 26: 1367-68.
31. Rozga J, Williams F, Ro M-S, Neuzil D, Giorgio T, Backfisch G et al. Development of a bioartificial liver: Properties and function of a hollow-fiber module inoculated with liver cells. Hepatology 1993; 17: 258-65.